Non-opioid Pain Patches Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 23-Jan-2022
No. of pages: 76

This report contains market size and forecasts of Non-opioid Pain Patches in global, including the following market information:

Global Non-opioid Pain Patches Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Non-opioid Pain Patches Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Non-opioid Pain Patches companies in 2021 (%)

The global Non-opioid Pain Patches market was valued at 649.7 million in 2021 and is projected to reach US$ 771.6 million by 2028, at a CAGR of 2.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lidocaine Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-opioid Pain Patches include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. In 2021,

The global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-opioid Pain Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-opioid Pain Patches Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Non-opioid Pain Patches Market Segment Percentages, by Type, 2021 (%)

- Lidocaine Patch

- Diclofenac Patch

- Methyl Salicylate Patch

- Capsaicin Patch

- Ketoprofen Patch

- Others

Global Non-opioid Pain Patches Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Non-opioid Pain Patches Market Segment Percentages, by Application, 2021 (%)

- Hospital Pharmacies

- Independent Pharmacies & Drug Stores

- Online Pharmacies

Global Non-opioid Pain Patches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Non-opioid Pain Patches Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-opioid Pain Patches revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Non-opioid Pain Patches revenues share in global market, 2021 (%)

Key companies Non-opioid Pain Patches sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Non-opioid Pain Patches sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Pfizer

- GlaxoSmithKline

- Johnson & Johnson

- Novartis AG

- Mylan N.V.

- Teva Pharmaceutical Industries

- Hisamitsu Pharmaceutical

- TEH SENG Pharmaceutical

- Teikoku Seiyaku

- IBSA Institut Biochimque SA

- Acorda Therapeutics

- Allergan PLC

- Endo International

Non-opioid Pain Patches Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Non-opioid Pain Patches Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-opioid Pain Patches Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-opioid Pain Patches Overall Market Size
2.1 Global Non-opioid Pain Patches Market Size: 2021 VS 2028
2.2 Global Non-opioid Pain Patches Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Non-opioid Pain Patches Sales: 2017-2028
3 Company Landscape
3.1 Top Non-opioid Pain Patches Players in Global Market
3.2 Top Global Non-opioid Pain Patches Companies Ranked by Revenue
3.3 Global Non-opioid Pain Patches Revenue by Companies
3.4 Global Non-opioid Pain Patches Sales by Companies
3.5 Global Non-opioid Pain Patches Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Non-opioid Pain Patches Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Non-opioid Pain Patches Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-opioid Pain Patches Players in Global Market
3.8.1 List of Global Tier 1 Non-opioid Pain Patches Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-opioid Pain Patches Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-opioid Pain Patches Market Size Markets, 2021 & 2028
4.1.2 Lidocaine Patch
4.1.3 Diclofenac Patch
4.1.4 Methyl Salicylate Patch
4.1.5 Capsaicin Patch
4.1.6 Ketoprofen Patch
4.1.7 Others
4.2 By Type - Global Non-opioid Pain Patches Revenue & Forecasts
4.2.1 By Type - Global Non-opioid Pain Patches Revenue, 2017-2022
4.2.2 By Type - Global Non-opioid Pain Patches Revenue, 2023-2028
4.2.3 By Type - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
4.3 By Type - Global Non-opioid Pain Patches Sales & Forecasts
4.3.1 By Type - Global Non-opioid Pain Patches Sales, 2017-2022
4.3.2 By Type - Global Non-opioid Pain Patches Sales, 2023-2028
4.3.3 By Type - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
4.4 By Type - Global Non-opioid Pain Patches Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Non-opioid Pain Patches Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Independent Pharmacies & Drug Stores
5.1.4 Online Pharmacies
5.2 By Application - Global Non-opioid Pain Patches Revenue & Forecasts
5.2.1 By Application - Global Non-opioid Pain Patches Revenue, 2017-2022
5.2.2 By Application - Global Non-opioid Pain Patches Revenue, 2023-2028
5.2.3 By Application - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
5.3 By Application - Global Non-opioid Pain Patches Sales & Forecasts
5.3.1 By Application - Global Non-opioid Pain Patches Sales, 2017-2022
5.3.2 By Application - Global Non-opioid Pain Patches Sales, 2023-2028
5.3.3 By Application - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
5.4 By Application - Global Non-opioid Pain Patches Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Non-opioid Pain Patches Market Size, 2021 & 2028
6.2 By Region - Global Non-opioid Pain Patches Revenue & Forecasts
6.2.1 By Region - Global Non-opioid Pain Patches Revenue, 2017-2022
6.2.2 By Region - Global Non-opioid Pain Patches Revenue, 2023-2028
6.2.3 By Region - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
6.3 By Region - Global Non-opioid Pain Patches Sales & Forecasts
6.3.1 By Region - Global Non-opioid Pain Patches Sales, 2017-2022
6.3.2 By Region - Global Non-opioid Pain Patches Sales, 2023-2028
6.3.3 By Region - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Non-opioid Pain Patches Revenue, 2017-2028
6.4.2 By Country - North America Non-opioid Pain Patches Sales, 2017-2028
6.4.3 US Non-opioid Pain Patches Market Size, 2017-2028
6.4.4 Canada Non-opioid Pain Patches Market Size, 2017-2028
6.4.5 Mexico Non-opioid Pain Patches Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Non-opioid Pain Patches Revenue, 2017-2028
6.5.2 By Country - Europe Non-opioid Pain Patches Sales, 2017-2028
6.5.3 Germany Non-opioid Pain Patches Market Size, 2017-2028
6.5.4 France Non-opioid Pain Patches Market Size, 2017-2028
6.5.5 U.K. Non-opioid Pain Patches Market Size, 2017-2028
6.5.6 Italy Non-opioid Pain Patches Market Size, 2017-2028
6.5.7 Russia Non-opioid Pain Patches Market Size, 2017-2028
6.5.8 Nordic Countries Non-opioid Pain Patches Market Size, 2017-2028
6.5.9 Benelux Non-opioid Pain Patches Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Non-opioid Pain Patches Revenue, 2017-2028
6.6.2 By Region - Asia Non-opioid Pain Patches Sales, 2017-2028
6.6.3 China Non-opioid Pain Patches Market Size, 2017-2028
6.6.4 Japan Non-opioid Pain Patches Market Size, 2017-2028
6.6.5 South Korea Non-opioid Pain Patches Market Size, 2017-2028
6.6.6 Southeast Asia Non-opioid Pain Patches Market Size, 2017-2028
6.6.7 India Non-opioid Pain Patches Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Non-opioid Pain Patches Revenue, 2017-2028
6.7.2 By Country - South America Non-opioid Pain Patches Sales, 2017-2028
6.7.3 Brazil Non-opioid Pain Patches Market Size, 2017-2028
6.7.4 Argentina Non-opioid Pain Patches Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-opioid Pain Patches Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Non-opioid Pain Patches Sales, 2017-2028
6.8.3 Turkey Non-opioid Pain Patches Market Size, 2017-2028
6.8.4 Israel Non-opioid Pain Patches Market Size, 2017-2028
6.8.5 Saudi Arabia Non-opioid Pain Patches Market Size, 2017-2028
6.8.6 UAE Non-opioid Pain Patches Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Non-opioid Pain Patches Major Product Offerings
7.1.4 Pfizer Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Non-opioid Pain Patches Major Product Offerings
7.2.4 GlaxoSmithKline Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Non-opioid Pain Patches Major Product Offerings
7.3.4 Johnson & Johnson Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Non-opioid Pain Patches Major Product Offerings
7.4.4 Novartis AG Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.4.5 Novartis AG Key News
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporate Summary
7.5.2 Mylan N.V. Business Overview
7.5.3 Mylan N.V. Non-opioid Pain Patches Major Product Offerings
7.5.4 Mylan N.V. Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.5.5 Mylan N.V. Key News
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Corporate Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharmaceutical Industries Key News
7.7 Hisamitsu Pharmaceutical
7.7.1 Hisamitsu Pharmaceutical Corporate Summary
7.7.2 Hisamitsu Pharmaceutical Business Overview
7.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Major Product Offerings
7.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.7.5 Hisamitsu Pharmaceutical Key News
7.8 TEH SENG Pharmaceutical
7.8.1 TEH SENG Pharmaceutical Corporate Summary
7.8.2 TEH SENG Pharmaceutical Business Overview
7.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Major Product Offerings
7.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.8.5 TEH SENG Pharmaceutical Key News
7.9 Teikoku Seiyaku
7.9.1 Teikoku Seiyaku Corporate Summary
7.9.2 Teikoku Seiyaku Business Overview
7.9.3 Teikoku Seiyaku Non-opioid Pain Patches Major Product Offerings
7.9.4 Teikoku Seiyaku Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.9.5 Teikoku Seiyaku Key News
7.10 IBSA Institut Biochimque SA
7.10.1 IBSA Institut Biochimque SA Corporate Summary
7.10.2 IBSA Institut Biochimque SA Business Overview
7.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Major Product Offerings
7.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.10.5 IBSA Institut Biochimque SA Key News
7.11 Acorda Therapeutics
7.11.1 Acorda Therapeutics Corporate Summary
7.11.2 Acorda Therapeutics Non-opioid Pain Patches Business Overview
7.11.3 Acorda Therapeutics Non-opioid Pain Patches Major Product Offerings
7.11.4 Acorda Therapeutics Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.11.5 Acorda Therapeutics Key News
7.12 Allergan PLC
7.12.1 Allergan PLC Corporate Summary
7.12.2 Allergan PLC Non-opioid Pain Patches Business Overview
7.12.3 Allergan PLC Non-opioid Pain Patches Major Product Offerings
7.12.4 Allergan PLC Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.12.5 Allergan PLC Key News
7.13 Endo International
7.13.1 Endo International Corporate Summary
7.13.2 Endo International Non-opioid Pain Patches Business Overview
7.13.3 Endo International Non-opioid Pain Patches Major Product Offerings
7.13.4 Endo International Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.13.5 Endo International Key News
8 Global Non-opioid Pain Patches Production Capacity, Analysis
8.1 Global Non-opioid Pain Patches Production Capacity, 2017-2028
8.2 Non-opioid Pain Patches Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-opioid Pain Patches Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-opioid Pain Patches Supply Chain Analysis
10.1 Non-opioid Pain Patches Industry Value Chain
10.2 Non-opioid Pain Patches Upstream Market
10.3 Non-opioid Pain Patches Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-opioid Pain Patches Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Non-opioid Pain Patches in Global Market
Table 2. Top Non-opioid Pain Patches Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Non-opioid Pain Patches Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Non-opioid Pain Patches Revenue Share by Companies, 2017-2022
Table 5. Global Non-opioid Pain Patches Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Non-opioid Pain Patches Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Non-opioid Pain Patches Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Non-opioid Pain Patches Product Type
Table 9. List of Global Tier 1 Non-opioid Pain Patches Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-opioid Pain Patches Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Non-opioid Pain Patches Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Non-opioid Pain Patches Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Non-opioid Pain Patches Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Non-opioid Pain Patches Sales (K Pcs), 2017-2022
Table 15. By Type - Global Non-opioid Pain Patches Sales (K Pcs), 2023-2028
Table 16. By Application - Global Non-opioid Pain Patches Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Non-opioid Pain Patches Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Non-opioid Pain Patches Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Non-opioid Pain Patches Sales (K Pcs), 2017-2022
Table 20. By Application - Global Non-opioid Pain Patches Sales (K Pcs), 2023-2028
Table 21. By Region - Global Non-opioid Pain Patches Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Non-opioid Pain Patches Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Non-opioid Pain Patches Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Non-opioid Pain Patches Sales (K Pcs), 2017-2022
Table 25. By Region - Global Non-opioid Pain Patches Sales (K Pcs), 2023-2028
Table 26. By Country - North America Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Non-opioid Pain Patches Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Non-opioid Pain Patches Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Non-opioid Pain Patches Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Non-opioid Pain Patches Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Non-opioid Pain Patches Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Non-opioid Pain Patches Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Non-opioid Pain Patches Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Non-opioid Pain Patches Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Non-opioid Pain Patches Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Non-opioid Pain Patches Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Non-opioid Pain Patches Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Non-opioid Pain Patches Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Non-opioid Pain Patches Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Non-opioid Pain Patches Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Non-opioid Pain Patches Sales, (K Pcs), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Non-opioid Pain Patches Product Offerings
Table 48. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Non-opioid Pain Patches Product Offerings
Table 51. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Johnson & Johnson Corporate Summary
Table 53. Johnson & Johnson Non-opioid Pain Patches Product Offerings
Table 54. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG Non-opioid Pain Patches Product Offerings
Table 57. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Mylan N.V. Corporate Summary
Table 59. Mylan N.V. Non-opioid Pain Patches Product Offerings
Table 60. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Teva Pharmaceutical Industries Corporate Summary
Table 62. Teva Pharmaceutical Industries Non-opioid Pain Patches Product Offerings
Table 63. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Hisamitsu Pharmaceutical Corporate Summary
Table 65. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Offerings
Table 66. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. TEH SENG Pharmaceutical Corporate Summary
Table 68. TEH SENG Pharmaceutical Non-opioid Pain Patches Product Offerings
Table 69. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Teikoku Seiyaku Corporate Summary
Table 71. Teikoku Seiyaku Non-opioid Pain Patches Product Offerings
Table 72. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. IBSA Institut Biochimque SA Corporate Summary
Table 74. IBSA Institut Biochimque SA Non-opioid Pain Patches Product Offerings
Table 75. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Acorda Therapeutics Corporate Summary
Table 77. Acorda Therapeutics Non-opioid Pain Patches Product Offerings
Table 78. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Allergan PLC Corporate Summary
Table 80. Allergan PLC Non-opioid Pain Patches Product Offerings
Table 81. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Endo International Corporate Summary
Table 83. Endo International Non-opioid Pain Patches Product Offerings
Table 84. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Non-opioid Pain Patches Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 86. Global Non-opioid Pain Patches Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Non-opioid Pain Patches Production by Region, 2017-2022 (K Pcs)
Table 88. Global Non-opioid Pain Patches Production by Region, 2023-2028 (K Pcs)
Table 89. Non-opioid Pain Patches Market Opportunities & Trends in Global Market
Table 90. Non-opioid Pain Patches Market Drivers in Global Market
Table 91. Non-opioid Pain Patches Market Restraints in Global Market
Table 92. Non-opioid Pain Patches Raw Materials
Table 93. Non-opioid Pain Patches Raw Materials Suppliers in Global Market
Table 94. Typical Non-opioid Pain Patches Downstream
Table 95. Non-opioid Pain Patches Downstream Clients in Global Market
Table 96. Non-opioid Pain Patches Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-opioid Pain Patches Segment by Type
Figure 2. Non-opioid Pain Patches Segment by Application
Figure 3. Global Non-opioid Pain Patches Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-opioid Pain Patches Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-opioid Pain Patches Revenue, 2017-2028 (US$, Mn)
Figure 7. Non-opioid Pain Patches Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Non-opioid Pain Patches Revenue in 2021
Figure 9. By Type - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 10. By Type - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 11. By Type - Global Non-opioid Pain Patches Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 13. By Application - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 14. By Application - Global Non-opioid Pain Patches Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 16. By Region - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 17. By Country - North America Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 18. By Country - North America Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 19. US Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 24. Germany Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 25. France Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 33. China Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 37. India Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 39. By Country - South America Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 40. Brazil Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Non-opioid Pain Patches Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Non-opioid Pain Patches Sales Market Share, 2017-2028
Figure 44. Turkey Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Non-opioid Pain Patches Revenue, (US$, Mn), 2017-2028
Figure 48. Global Non-opioid Pain Patches Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Non-opioid Pain Patches by Region, 2021 VS 2028
Figure 50. Non-opioid Pain Patches Industry Value Chain
Figure 51. Marketing Channels
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs